Erika Carmel-Tech Ltd (TLV:ERKA)
40.00
-3.60 (-8.26%)
Oct 29, 2026, 2:21 PM IST
Erika Carmel-Tech Revenue
Erika Carmel-Tech had revenue of 16.85M ILS in the half year ending June 30, 2026, a decrease of -11.74%. This brings the company's total for the last twelve months to 33.43M, down -15.66% year-over-year. In the year 2025, Erika Carmel-Tech had annual revenue of 37.34M, down -1.64%. That makes Erika Carmel-Tech the 36,999th largest company in the world by revenue and 380th in Israel.
Revenue (ttm)
33.43M
Revenue Growth
-15.66%
P/S Ratio
0.60
Revenue / Employee
742.80K
Employees
45
Market Cap
18.43M
Revenue by Geography
- Israel 35.76M 95.8%
- Europe 1.53M 4.1%
- Others 51.00K 0.1%
- North America 1.00K 0.0%
Fiscal year ended Dec 31, 2025 See the full Erika Carmel-Tech breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 37.34M | -621.00K | -1.64% |
| Dec 31, 2024 | 37.96M | 8.08M | 27.03% |
| Dec 31, 2023 | 29.88M | -20.44M | -40.62% |
| Dec 31, 2022 | 50.32M | -46.53M | -48.04% |
| Dec 31, 2021 | 96.86M | 11.08M | 12.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Danel (Adir Yeoshua) | 2.98B |
| Amal Holdings A.D. | 2.25B |
| Rafa Laboratories | 459.86M |
| Bait Bakfar | 115.76M |
| Identi Healthcare | 12.44M |
| Evogene | 4.94M |
| Nextage Therapeutics | 2.51M |
| Can-Fite BioPharma | 1.21M |